UnknownNot Applicable

A Sample Collection Study Utilizing DermTech's Non-invasive Adhesive Patch Biopsy Kits

United States1,000 participantsStarted 2020-10-01

Plain-language summary

This sample collection study will recruit subjects with a variety of skin conditions from up to 15 geographically dispersed sites in the United States. Skin samples will be collected with the DermTech Adhesive Patch Kit from both lesional and non-lesional skin. Subjects may also be asked to return at a future data for additional collections. Collected skin samples will be analyzed for gene expression information, DNA and the microbiome.

Who can participate

Age range21 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Males and females at least 21 years of age;
✓. Have a dermatologic condition of interesting including but not limited too; atopic dermatitis, atopic asthma, skin cancers (i.e., basal, and squamous carcinoma, melanoma, etc.), lupus, rheumatoid and psoriatic arthritis, gutate and plaque psoriasis, palmoplantar psoriasis, palmoplantar contact dermatitis, fungal infections and cutaneous T cell Lymphoma that can be non-invasively biopsied with DermTech's adhesive patch kit;
✓. Willing to allow additional DermTech adhesive patch biopsies to be performed; and
✓. Willing to provide informed consent to participate in this trial.

Exclusion criteria

✕. Required a surgical biopsy or excision prior to a PLA on that lesion of interest;
✕. Has an ulcerated or bleeding lesion that could cofound the PLA results;
✕. Has a suspicious lesion(s) in an area that was previously surgically biopsied;
✕. Has an allergy to tape or latex rubber; and
✕. Receipt of any investigational drug therapy within four weeks of study enrollment, or concurrent participation in another interventional clinical study deemed by the treating physician to potentially influence this study.

What they're measuring

Gene Expression Analysis

Timeframe: 24 months

Trial details

NCT IDNCT04668846

SponsorDermTech

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-10-30

Contact for this trial

James Rock

18582052736 jrock@dermtech.com

View on ClinicalTrials.gov More Dermatologic Diseases trials